Company / Working Capital per Share
Tvardi Therapeutics, Inc. Working Capital per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$8.78
FY2024
5-year range
$1.68 / $8.78
FY2020-FY2024
Trend
+421.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share changed +421% YoY in FY2024, a notable deviation from the 9-year average annual change of +43%.
Based on SEC 10-K filings.
8.78 in FY2024 with a 5-year CAGR of +23.1%.
Improved from $2.72 to $8.78 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +41.2%
- 5-Year CAGR
- +23.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, working capital per share increased 421.5% year-over-year.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $8.78 | +421.5% |
| FY2023 | $1.68 | -38.1% |
| FY2022 | $2.72 | -12.9% |
| FY2021 | $3.12 | -17.4% |
| FY2020 | $3.78 | +21.8% |
| FY2019 | $3.10 | -20.6% |
| FY2018 | $3.91 | +23.3% |
| FY2017 | $3.17 | +73.1% |
| FY2016 | $1.83 | -59.7% |
| FY2015 | $4.55 | -60.8% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026